Follow
Michael J. Mina, MD, PhD
Michael J. Mina, MD, PhD
Harvard School of Public Health, Harvard Medical School
Verified email at hsph.harvard.edu
Title
Cited by
Cited by
Year
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
K Bjornevik, M Cortese, BC Healy, J Kuhle, MJ Mina, Y Leng, SJ Elledge, ...
Science 375 (6578), 296-301, 2022
12322022
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
DB Larremore, B Wilder, E Lester, S Shehata, JM Burke, JA Hay, ...
Science advances 7 (1), eabd5393, 2021
8282021
Rethinking Covid-19 test sensitivity—a strategy for containment
MJ Mina, R Parker, DB Larremore
New England Journal of Medicine 383 (22), e120, 2020
7972020
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality
MJ Mina, CJE Metcalf, RL De Swart, A Osterhaus, BT Grenfell
Science 348 (6235), 694-699, 2015
4472015
To interpret the SARS-CoV-2 test, consider the cycle threshold value
MR Tom, MJ Mina
Clinical Infectious Diseases 71 (16), 2252-2254, 2020
4272020
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ...
Science 366 (6465), 599-606, 2019
3822019
Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
DB Larremore, B Wilder, E Lester, S Shehata, JM Burke, JA Hay, T Milind, ...
MedRxiv, 2020
2502020
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
CM Saad-Roy, CE Wagner, RE Baker, SE Morris, J Farrar, AL Graham, ...
Science 370 (6518), 811-818, 2020
2482020
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
CM Saad-Roy, SE Morris, CJE Metcalf, MJ Mina, RE Baker, J Farrar, ...
Science 372 (6540), 363-370, 2021
2122021
COVID-19 testing: One size does not fit all
MJ Mina, KG Andersen
Science 371 (6525), 126-127, 2021
2122021
Estimating epidemiologic dynamics from cross-sectional viral load distributions
JA Hay, L Kennedy-Shaffer, S Kanjilal, NJ Lennon, SB Gabriel, M Lipsitch, ...
Science 373 (6552), eabh0635, 2021
1702021
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ...
Science immunology 5 (47), eabc6347, 2020
1662020
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
MJ Mina, TE Peto, M García-Fiñana, MG Semple, IE Buchan
The Lancet 397 (10283), 1425-1427, 2021
1632021
JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function
AC Monteiro, R Sumagin, CR Rankin, G Leoni, MJ Mina, DM Reiter, ...
Molecular biology of the cell 24 (18), 2849-2860, 2013
1252013
Drivers of airborne human-to-human pathogen transmission
S Herfst, M Böhringer, B Karo, P Lawrence, NS Lewis, MJ Mina, ...
Current opinion in virology 22, 22-29, 2017
1212017
Vaccine nationalism and the dynamics and control of SARS-CoV-2
CE Wagner, CM Saad-Roy, SE Morris, RE Baker, MJ Mina, J Farrar, ...
Science 373 (6562), eabj7364, 2021
1022021
Reopening scenarios
D Baqaee, E Farhi, MJ Mina, JH Stock
National Bureau of Economic Research, 2020
922020
Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice
MJ Mina, JA McCullers, K Keith P
mBio 5 (1), e01040-13, 2014
912014
The role of influenza in the severity and transmission of respiratory bacterial disease
MJ Mina, KP Klugman
The Lancet Respiratory Medicine 2 (9), 750-763, 2014
872014
Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity
H Clapham, J Hay, I Routledge, S Takahashi, M Choisy, D Cummings, ...
Emerging infectious diseases 26 (9), 1978, 2020
832020
The system can't perform the operation now. Try again later.
Articles 1–20